2018 American Transplant Congress

June 2-6, 2018 in Seattle, WA

View by Title View Sessions

View by Date

Monday, June 4, 2018

5:42pm-5:54pm: Brincidofovir Was Used to Successfully Treat Adenovirus Infections in Solid Organ Transplant Recipients and Other Immunocompromised Patients

D. Florescu,¹ M. Grimley,² G. Papanicolaou,³ V. Prasad,⁴ E. Vainorius,⁵ G. Chittick,⁵ T. Brundage,⁵ G. Nichols.⁵

Concurrent Session: Addressing Re-Emerging Infectious Challenges to Transplantation • Room 602/603/604

5:42pm-5:54pm: Demographic and Geographic Differences in the Proportion of Liver Disease Deaths Captured by the Transplant Waitlist in the United States, 2011 – 2015

K. Ross,¹ R. Lynch,² D. Goldberg,³ R. Patzer.^1,2

Concurrent Session: Non-Organ Specific: Economics, Public Policy, Allocation, Ethics - 1 • Room 4C-4

5:42pm-5:54pm: Development and Validation of FLF-Transplant Score to Predict Mortality of Status 1A Candidates

Z. Guo, B. Chen, Q. Zhao, E. Xin, Z. Zhang, L. Wang, X. He, G. Chen.

Concurrent Session: Liver: MELD, Allocation and Donor Issues - 1 • Room 6B

5:42pm-5:54pm: Do Reconstruction Techniques for Two Renal Arteries Affect Long-Term Graft Survival after Living Donor Renal Transplantation?

S. Yamanaga, P. Stock, M. Tavkol, S-.M. Kang.

Concurrent Session: Kidney: Surgical Considerations • Room 210

5:42pm-5:54pm: Dual Inhibition of PI3K and mTORC2 Causes ERK Hyperactivation Induced by HLA-II Antibody in Human Endothelium

Y-.P. Jin, E. Reed.

Concurrent Session: Endothelial Cell Biology • Room 615/616/617

5:42pm-5:54pm: Impact of the New KAS on Transplant Rates in Highly-HLA Sensitized (HS) Patients after Desenstization (DES): 3yrs Post Implementation

A. Vo, E. Huang, N. Ammerman, S. Williamson, C. Myers, A. Peng, R. Najjar, S. Sethi, K. Lim, S. Jordan.

Concurrent Session: Kidney Immunosuppression: Desensitization • Room 4B

5:42pm-5:54pm: Pancreas Graft Function >10 Years: The Cumulative US Experience

A. Gruessner,¹ M. Laftavi,² O. Pankewycz,² R. Gruessner.¹

Concurrent Session: Pancreas and Islet - 1 • Room 4C-3

5:42pm-5:54pm: Pre-Donation eGFR, Early Post-Donation eGFR, and Subsequent ESRD Risk in Living Kidney Donors

A. Massie,¹ L. Fahmy,¹ M. Henderson,¹ A. Thomas,¹ J. Snyder,² D. Segev.¹

Concurrent Session: Kidney Living Donor: Long Term Outcomes • Room 6A

5:42pm-5:54pm: Predictors of Graft Survival at the Time of a Kidney Transplant Indication Biopsy

G. Einecke,¹ J. Reeve,^2,3 P. Halloran.^2,4

Concurrent Session: Kidney Complications: Late Graft Failure • Room 6E

5:42pm-5:54pm: Robust Hematopoietic Mixed Chimerism and Donor-Specific Skin Allograft Tolerance after Non-Genotoxic Anti-CD117 Immunotoxin Conditioning and Donor Bone Marrow Allotransplantation

Z. Li,¹ A. Czechowicz,^2,3,4,5,6,7 A. Scheck,^2,3,4,5,6 D. Rossi,^3,4,5,6 P. Murphy.¹

Concurrent Session: Strategies to Promote Transplant Tolerance • Room 606/607